Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Industry News
Search Articles:
Novartis Kisqali® first and only CDK4/6 inhibitor indicated in US as first-line therapy
Novartis announced a new approval for Kisqali® (ribociclib) from the FDA for women with hormone-receptor positive, human epidermal growth factor receptor-2 negative advanced or metastatic breast cancer.
July 18, 2018
More...
Email This Page
to a Friend
Print This
Page